AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.
about
sameAs
A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits".Phenolic fraction of tobacco smoke condensate potentiates benzo[a]pyerene diol epoxide-induced cell transformation: role of protein kinase C.Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.Ectopic ERK expression induces phenotypic conversion of C10 cells and alters DNA methyltransferase expression.Inhibition of benzopyrene diol epoxide-induced apoptosis by cadmium(II) is AP-1-independent: role of extracelluler signal related kinaseSesquiterpene lactones isolated from indigenous Middle Eastern plants inhibit tumor promoter-induced transformation of JB6 cells.ERK and JNK activation is essential for oncogenic transformation by v-Rel.Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase.Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPKQuercetin-3-methyl ether suppresses proliferation of mouse epidermal JB6 P+ cells by targeting ERKs.Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genesCocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinaseAn integrated understanding of the physiological response to elevated extracellular phosphate.The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEKTumor necrosis factor and cancer, buddies or foes?Cellular dichotomy between anchorage-independent growth responses to bFGF and TPA reflects molecular switch in commitment to carcinogenesis.Withaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells.5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells.A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells.Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.Prolonged overexpression of Wnt10b induces epidermal keratinocyte transformation through activating EGF pathway.Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.EGFR-mediated Akt and MAPKs signal pathways play a crucial role in patulin-induced cell proliferation in primary murine keratinocytes via modulation of Cyclin D1 and COX-2 expression.Does increase in DNA repair allow "tolerance-to-insult" in chemical carcinogenesis? Skin tumor experiments with MGMT-overexpressing mice.Transient receptor potential melastatin type 7 channels are involved in zinc-induced apoptosis in gastric cancer
P2860
Q33414478-A5AC5472-C1F5-4BC4-8DCB-C231F0E04132Q33701466-3A5E1C48-762E-412D-B148-E44792DBFF2EQ33706073-20175170-B104-4A28-97AF-A011216B339AQ33721782-0FD6946A-25BF-40A0-BCAE-446684F3DF99Q34258528-327E891D-F270-44A0-B800-F738EF1FB97DQ34275452-5BBC8952-6DC6-407F-A160-97ED17E54493Q34331288-14590617-3EAB-4A87-B137-44E3CDF42ED9Q34351185-2A670739-9C87-47C6-A0BB-72D5ED1FD029Q34410831-70C804A1-45D1-4027-AD9F-1B2380E7DD97Q35020439-06BF2AF2-79AE-4EC5-875E-023FF3954B6DQ35730661-CA6B404A-C599-452E-A2A9-53E495E7A4F8Q36512011-84C1261B-2C27-43A3-BC6E-5A356E13B366Q36765030-D2A20E37-8FC1-4F83-8D1E-FED648B5D562Q36777979-4E533800-07B5-4427-9182-9C3882B43473Q36986316-01529009-5F50-48AB-ACF6-F585A80F921BQ37022473-19F47DA2-DCA3-4625-AB22-892BC8B47CA1Q37073092-A3508907-1381-43C2-9FC8-118FB0E19E17Q38353146-A3B413B5-D53E-4316-8CF3-4411154AF7D2Q39252231-B3CA8B14-D56D-445F-9472-75FBD37EDBFFQ39576677-44ED2C4E-AF5C-4781-B76F-8FA5E7230920Q40424221-11CAEAA4-68EB-4DF8-A845-73308740C43AQ40440777-07D26BDE-38A7-45CB-95CF-8B2356908569Q40570030-7B1526A7-1CE4-43A7-AECA-0F77676828D7Q41529211-B0713534-4195-42F7-A662-93C55DBEAFBEQ42142390-B362E6A2-A086-41E9-9E0C-6E5C46269D17Q46096656-5185BA6F-7B3E-4F7A-ADBD-71FEDE65F867Q46701473-B2A65F8D-D1BF-4E7E-A2F0-C2E8A83D4086Q58304077-72908FA9-F79B-4AE1-BDCB-7C3F48967584
P2860
AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model
@nl
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model.
@ast
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model.
@en
type
label
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model
@nl
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model.
@ast
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model.
@en
prefLabel
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model
@nl
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model.
@ast
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model.
@en
P2860
P356
P1476
AP-1, NF-kappa-B, and ERK acti ...... the mouse epidermal JB6 model
@en
P2093
Nancy H Colburn
Thomas J Weber
P2860
P304
P356
10.1289/EHP.02110865
P407
P577
2002-09-01T00:00:00Z